POSTER SESSION III Tuesday, March 9, 2004   —  9:30 AM - 12:00 Noon Exhibit Hall B and C BREAST PATHOLOGY 1 Axillary Micrometastases in Breast Carcinoma Do Not Influence Patient Survival or Disease Recurrence (87) HM Brown, MT Tees, EJ Wilkinson - University of Florida, Gainesville, FL 2 "Isolated Tumor Cells" in Sentinel Lymph Nodes of Breast Carcinoma: Study of 36 Cases (187) M Rivera, SL Merlin, A Gopalan, X Chen, T Scognamiglio, SA Hoda - New York-Presbyterian Hospital/Weill-Cornell Medical Center, New York, NY 3 Sentinel Lymph Node Metastasis of Breast Carcinoma Is Directly Proportional to the Size of Invasive Tumor but Does Not Depend on Increased Microvascular Density (189) S Sanati, S Soundararajan, Z Gatalica - Creighton University Medical Center, Omaha, NE; The University of Texas Medical Branch, Galveston, TX 4 Tumor Characteristics Predictive of Sentinel Lymph Node Metastases in Patients with Breast Cancer (142) M Koker, PC Lucas, K Griffith, M Sabel, L Newman, MA Rubin, CG Kleer - University of Michigan, Ann Arbor, MI; Brigham and Women's Hospital, Boston, MA 5 Micrometastatic (mM) Mammary Carcinoma in Axillary Sentinel Lymph Nodes (SLN) Is Not a Displacement Artifact (175) L Petroff, A Ricci, Jr - Hartford Hospital, Hartford, CT 6 "Separation Artefact" in Breast Cancer: An Early Stage of Lymphovascular Invasion (82) SH Barsky - UCLA School of Medicine, Los Angeles, CA 7 False Positive Lymph Nodes in Breast Carcinoma. Do They Exist? (149) MD Legmann, S Jaffer, IJ Bleiweiss - Mount Sinai School of Medicine, New York, NY 8 Absence of E-cadherin Expression in Invasive Ductal Carcinoma of Breast: A Significant Predictor of Lymph Node Metastasis (138) E Kim, L Middleton, B Arun, A Sahin - UT M. D. Anderson Cancer Center, Houston, TX 9 Immunohistochemical Detected Breast Cancer Node Metastases: Practical Considerations about the New AJCC Classification (195) I Soubeyran, I de Mascarel, G MacGrogan, V Picot, S Mathoulin-Pélissier - Institut Bergonié, Bordeaux, France 10 Correlation of Modified Bloom-Richardson Score and Tumor Size with the Incidence of Lymph Node Metastasis in Grade I Carcinomas of the Breast (124) K Harrell, S Logani, GM Oprea-Ilies - Emory University Hospital, Grady Memorial Hospital, Atlanta, GA 11 Ploidy Status Helps in Reproducibilty of Nuclear Grading in Invasive Breast Carcinoma (116) FU Garcia, MM Haber, SS Selim, C Hanau, S Hou, C Minimo - Drexel University College of Medicine, Philadelphia, PA 12 The Prognostic Value of Nuclear Grade and Multiple Intracellular Molecular Abnormalities in Breast Cancer (104) R Dawson, C Smith, A Pollice, R Day, YL Liu, S Shackney, JF Silverman - Allegheny General Hospital, Pittsburgh, PA; University of Pittsburgh, Pittsburgh, PA 13 Is Nottingham Prognostic Index (NPI) Useful after Induction Chemotherapy in Operable Breast Cancer? (173) FM Penault-Llorca, S Amat, H Cure, M Delatour, G Lebouedec, V Feillel, P Chollet - Centre Jean Perrin, Clermont-Ferrand, France 14 A New Semi-Automated Method of Grading Breast Carcinoma Based on a Multivariant Analysis of 527 Cases (201) O Tawfik, F Fan, M Davis, I Damjanov, P Thomas, B Kimler - Kansas University Medical Center, Kansas City, KS 15 Breast Cancer Grade vs Proliferation Index (PI) (162) JS Meyer, A Glass, C Milikowski, J Russo, BA Zehnbauer, C Alvarez, K Lister, N Olson, I Russo, P Rudolph, R Parwaresch - Cooperative Breast Cancer Tissue Resource (CBCTR) St. Luke's H., St. Louis, MO; Kaiser Permanente, Portland, OR; U. Miami, FL; Fox Chase PA; Washington U.; Institute for Hematopathology, U. Kiel, Germany 16 Refined Morphologic Criteria for Tubular Carcinoma To Retain Its Favorable Outcome Status in Contemporary Breast Carcinoma Patients Treated with Breast Conserving Therapy (119) NS Goldstein, LL Kestin, FA Vicini - William Beaumont Hospital, Royal Oak, MI 17 Image Analysis of Breast Cancer Prognostic Markers: Correlate of Tumor Differentiation or Disease Stage (127) DB Herring, DA Castrodale, JE Coad - West Virginia University, Morgantown, WV